Tirzepatide-RUT is a cutting-edge innovative agent designed to mimic the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This combined incretin mimetic exerts its effects by binding to the GLP-1 read more and GIP receptors, thereby promoting insulin secretion in a glucose-sensitive manner. The